共 50 条
- [43] Transarterial chemoembolization combined with lenvatinib plus tislelizumab for unresectable hepatocellular carcinoma: a multicenter cohort study FRONTIERS IN IMMUNOLOGY, 2024, 15
- [46] The C-Reactive Protein to Albumin Ratio Is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: A Large Cohort Study CardioVascular and Interventional Radiology, 2022, 45 : 1295 - 1303